Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome-Reference-Cited by-同舟云学术

Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome

Published:2020-10-12 Issue:10 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bala Malgorzata M¹²,Celinska-Lowenhoff Magdalena³,Szot Wojciech¹,Padjas Agnieszka³,Kaczmarczyk Mateusz⁴,Swierz Mateusz J¹²,Undas Anetta⁵

Affiliation:

1. Chair of Epidemiology and Preventive Medicine, Department of Hygiene and Dietetics; Jagiellonian University Medical College; Krakow Poland

2. Systematic Reviews Unit; Jagiellonian University Medical College; Krakow Poland

3. 2nd Department of Internal Medicine, Department of Allergy and Immunology; Jagiellonian University Medical College; Krakow Poland

4. Systematic Reviews Unit - Polish Cochrane Branch; Jagiellonian University Medical College; Krakow Poland

5. Institute of Cardiology; Jagiellonian University Medical College; Krakow Poland

Publisher

Wiley

Subject

Pharmacology (medical)

Reference115 articles.

1. Erratum. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome;New England Journal of Medicine,2003

2. A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies;Crowther;Blood,2002

3. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome;Crowther;New England Journal of Medicine,2003

4. The use of warfarin and low-dose aspirin in patients with antiphospholipid syndrome;Kondratyeva;Lupus,2010

5. Recurrences of thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin;Kondratyeva;Terapevticheskii Arkhiv,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic screening for risk of cerebral venous thrombosis in young patients taking oral contraceptives;Medical alphabet;2023-10-18

2. Anticoagulantes de acción directa en el síndrome antifosfolípido. Revisión sistemática;Medicina Clínica;2023-07

3. Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases;European Journal of Vascular and Endovascular Surgery;2023-05

4. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature;Seminars in Thrombosis and Hemostasis;2023-03-30

5. Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch;Lupus;2023-03-20